OpenAI & Babylon Revolutionize Drug Trials, Pathos AI Raises $365M for Oncology - Life AI Weekly #18

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in Healthcare and Life Sciences AI. This week, we explore a range of exciting developments, including OpenAI's collaboration with Babylon to enhance drug trial predictions, and Nanyang Biologics' innovative use of AI in drug discovery. Additionally, Viva Biotech has launched a new AI-driven drug discovery platform, marking a significant step forward in the field.

In the realm of business and investments, Akido Labs has secured $60 million to advance its AI healthcare system, while Pathos AI has raised $365 million for oncology drug development. Meanwhile, Oath Surgical has obtained $10 million to develop AI-powered surgery centers, and Synyi AI has launched an AI Doctor Clinic in Saudi Arabia. These stories highlight the growing impact of AI technologies in transforming healthcare and life sciences industries.

Akido Labs, Inc. has raised $60 million to expand its ScopeAI system for healthcare integration. Pathos AI secured $365 million to advance its oncology drug development platform. Rad AI received an $8 million investment to further develop AI applications in healthcare.

OpenAI and Babylon Biosciences are collaborating to enhance AI models for predicting drug trial successes, aiming to reduce costs in the biopharma industry. Nanyang Biologics, a spin-off from Nanyang Technological University, is using its DTIGN platform to transform drug discovery in South-East Asia by focusing on plant-derived compounds and employing advanced AI techniques. Viva Biotech has introduced its AI-Driven Drug Discovery platform, featuring three core modules aimed at improving drug research efficiency and reducing costs.

Axtria and Genloop have teamed up to develop large language models tailored for the life sciences industry, focusing on regulatory compliance and system integration. UCB and Domino Data Lab have announced a strategic collaboration to modernize the Statistical Computing Environment for the life sciences industry, aiming to enhance clinical research and regulatory compliance.

Oath Surgical has secured $10 million to develop AI-powered surgery centers in Portland. Serviceaide reported a data breach affecting 483,000 Catholic Health patients. IMVARIA shared clinical results of its AI diagnostic tool at ATS 2025.